BIOGEN INC. - Common Stock (BIIB)

CUSIP: 09062X103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
147,079,094
Total 13F shares
139,668,143
Share change
+8,248,959
Total reported value
$24,578,175,279
Put/Call ratio
65%
Price per share
$175.99
Number of holders
985
Value change
+$1,492,219,917
Number of buys
454
Number of sells
376

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
12%
17,289,235
$2,421,876,038 30 Sep 2025
13F
PRIMECAP MANAGEMENT CO/CA/
13D/G 13F
Company
10%
14,954,697
$2,094,853,956 $0 30 Sep 2025
BlackRock, Inc.
13F 13D/G
Company
8.5%
from 13D/G
14,763,952
$2,068,134,447 30 Sep 2025
FMR LLC
13D/G 13F
Company
6.4%
9,413,062
$1,656,604,787 $0 31 Dec 2025
STATE STREET CORP
13D/G 13F
STATE STREET CORPORATION · Company
5%
7,321,168
$1,025,549,213 $0 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.9%
4,246,504
$594,850,279 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.8%
4,068,781
$567,740,241 30 Sep 2025
13F
Point72 Asset Management, L.P.
13F
Company
2.6%
3,872,901
$542,516,040 30 Sep 2025
13F
Invesco Ltd.
13F
Company
1.6%
2,418,127
$338,731,160 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
1.5%
2,251,535
$315,395,300 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.2%
1,783,581
$248,809,475 30 Sep 2025
13F
Legal & General Group Plc
13F
Company
1.1%
1,593,399
$223,203,335 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
1%
1,499,332
$210,026,427 30 Sep 2025
13F
Pacer Advisors, Inc.
13F
Company
0.99%
1,451,249
$203,290,960 30 Sep 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.98%
1,439,208
$201,604,257 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
0.92%
1,359,424
$190,428,112 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.86%
1,268,350
$177,670,522 30 Sep 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.84%
1,234,149
$172,879,592 30 Sep 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.84%
1,231,302
$172,480,783 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.83%
1,220,018
$170,900,120 30 Sep 2025
13F
Alexander J. Denner
3/4/5
Director
class O/S missing
658,099
$163,208,552 15 Jun 2022
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.76%
1,123,349
$157,358,728 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.76%
1,111,190
$155,655,495 30 Sep 2025
13F
T. Rowe Price Investment Management, Inc.
13F
Company
0.73%
1,067,482
$149,533,000 30 Sep 2025
13F
VAN ECK ASSOCIATES CORP
13F
Company
0.73%
1,066,931
$149,456,000 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.72%
1,063,586
$148,987,148 30 Sep 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.66%
965,457
$135,242,000 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.66%
964,406
$135,093,992 30 Sep 2025
13F
Man Group plc
13F
Company
0.62%
918,025
$128,596,942 30 Sep 2025
13F
MARSHALL WACE, LLP
13F
Company
0.6%
887,661
$124,343,553 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.6%
884,701
$123,928,907 30 Sep 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.59%
873,094
$122,293,283 30 Sep 2025
13F
Alyeska Investment Group, L.P.
13F
Company
0.57%
845,277
$118,406,402 30 Sep 2025
13F
FIRST TRUST ADVISORS LP
13F
Company
0.57%
840,557
$117,745,157 30 Sep 2025
13F
Pictet Asset Management Holding SA
13F
Company
0.52%
770,855
$107,698,024 30 Sep 2025
13F
AustralianSuper Pty Ltd
13F
Company
0.51%
751,386
$105,254,151 30 Sep 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.5%
729,316
$102,162,586 30 Sep 2025
13F
Rakuten Investment Management, Inc.
13F
Company
0.14%
198,572
$99,137,071 30 Sep 2025
13F
Employees Provident Fund Board
13F
Company
0.48%
704,196
$98,643,775 30 Sep 2025
13F
Amundi
13F
Individual
0.42%
618,309
$95,250,502 30 Sep 2025
13F
Robeco Institutional Asset Management B.V.
13F
Company
0.46%
671,054
$94,001,243 30 Sep 2025
13F
UBS Group AG
13F
Company
0.43%
638,965
$89,506,219 30 Sep 2025
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Company
0.39%
569,253
$79,740,963 30 Sep 2025
13F
CAUSEWAY CAPITAL MANAGEMENT LLC
13F
Company
0.39%
567,518
$79,497,885 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.34%
498,120
$69,777,000 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.32%
477,924
$66,947,594 30 Sep 2025
13F
HSBC HOLDINGS PLC
13F
Company
0.3%
447,518
$62,594,417 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.3%
441,082
$61,786,767 30 Sep 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.3%
439,109
$61,510,389 30 Sep 2025
13F
Swiss National Bank
13F
Company
0.29%
422,400
$59,169,792 30 Sep 2025
13F

Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2025

As of 31 Dec 2025, BIOGEN INC. - Common Stock (BIIB) was held by 985 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 139,668,143 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., PRIMECAP MANAGEMENT CO/CA/, FMR LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, Point72 Asset Management, L.P., NORGES BANK, and MORGAN STANLEY. This page lists 985 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
894
Q4 2025 holders
985
Holder diff
91
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.